Today's Date
Treatment With hOKT3gamma1(Ala-Ala) in T1DM
(
Herold / NDB01
)
ITN Protocol #:
ITN007AI
Branded Name:
Herold / NDB01
Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Terminated
Summary:
Phase II Multiple Dose Treatment of Type 1 Diabetes Mellitus With hOKT3gamma1(Ala-Ala)
Clinical Operations Manager
ITN Biologist
NIAID Project Manager
Study Personnel: